Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares KNSA
$77.83
-0.41%
at last close
Analyst Consensus
- Consensus Rating
- Buy (8 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $87.38
- Implied Upside
- +12.3%
- Price Target Range
- $60.00 – $107.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-30 | Goldman SachsPaul Choi |
Maintains | Buy | $75 → $90 |
| 2026-07-29 | JP MorganAnupam Rama |
Maintains | Overweight | $72 → $107 |
| 2026-07-29 | Canaccord GenuityEdward Nash |
Maintains | Buy | $64 → $98 |
| 2026-07-29 | WedbushDavid Nierengarten |
Maintains | Outperform | $72 → $99 |
| 2026-07-29 | CitigroupGeoff Meacham |
Maintains | Buy | $60 → $100 |
| 2026-07-23 | Goldman SachsPaul Choi |
Maintains | Buy | $60 → $75 |
| 2026-07-13 | Wells FargoEva Fortea Verdejo |
Maintains | Overweight | $57 → $74 |
| 2026-06-29 | WedbushDavid Nierengarten |
Maintains | Outperform | $59 → $72 |
| 2026-04-29 | Canaccord GenuityEdward Nash |
Maintains | Buy | $62 → $64 |
| 2026-04-29 | CitigroupGeoff Meacham |
Maintains | Buy | $50 → $60 |
| 2026-04-29 | WedbushDavid Nierengarten |
Maintains | Outperform | $58 → $59 |
| 2026-04-29 | Wells FargoEva Fortea Verdejo |
Maintains | Overweight | $53 → $57 |
| 2026-04-28 | JefferiesRoger Song |
Maintains | Buy | $58 → $71 |
| 2026-04-16 | WedbushDavid Nierengarten |
Maintains | Outperform | $53 → $58 |
| 2026-02-25 | Wells FargoEva Fortea Verdejo |
Maintains | Overweight | $50 → $53 |
| 2026-02-25 | WedbushDavid Nierengarten |
Maintains | Outperform | $50 → $53 |
| 2026-02-19 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $62 |
| 2026-01-13 | WedbushDavid Nierengarten |
Maintains | Outperform | $48 → $50 |
| 2025-10-29 | Goldman SachsPaul Choi |
Maintains | Buy | $45 → $55 |
| 2025-10-17 | CitigroupGeoff Meacham |
Maintains | Buy | $45 → $50 |
| 2025-10-13 | WedbushDavid Nierengarten |
Maintains | Outperform | $38 → $44 |
| 2025-09-29 | TD CowenNicholas Lorusso |
Initiates coverage on | Buy | $60 |
| 2025-09-25 | Wells FargoEva Fortea Verdejo |
Maintains | Overweight | $42 → $45 |
| 2025-07-29 | JefferiesRoger Song |
Maintains | Buy | $45 → $54 |
| 2025-07-09 | Wells FargoEva Fortea Verdejo |
Maintains | Overweight | $30 → $42 |
| 2025-04-29 | JefferiesRoger Song |
Maintains | Buy | $40 → $45 |
| 2025-04-16 | WedbushDavid Nierengarten |
Reiterates | Outperform | $34 |
| 2025-03-13 | CitigroupGeoff Meacham |
Initiates coverage on | Buy | $40 |
| 2024-11-05 | JP MorganAnupam Rama |
Maintains | Overweight | $39 → $40 |
| 2024-10-30 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $30 → $35 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $77.83
- Market Cap
- $6.10 billion
- 52-Week Range
- $26.27 – $82.94
- Average Volume
- 689K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.